Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Summary: Plasmodium vivax infections are characterised by recurrent bouts of blood-stage parasitaemia. Understanding the genetic relatedness of recurrences can help distinguish whether these are caused by relapse, reinfection, or recrudescence, which is critical to understand treatment efficacy and transmission dynamics. We developed PvAmpseq, an amplicon sequencing assay targeting 11 SNP-rich regions of the P. vivax genome. PvAmpSeq was applied to field isolates from a clinical trial in the Solomon Islands and a longitudinal observational cohort in Peru, and statistical models were applied for genetic classification of recurrences. In the Solomon Islands trial, where participants received antimalarials at baseline, half of the recurrent infections were caused by parasites with >50% relatedness to the baseline infection (identity-by-descent), with statistical models providing further classification as probable relapses and recrudescences, although with wide uncertainty. In the Peruvian cohort, half of the recurrent infections were caused by parasites with >22% relatedness to the baseline infection. PvAmpSeq provides high-resolution genotyping to characterise P. vivax recurrences, offering insights into transmission and treatment outcomes. We also discuss the nuances and limitations of available statistical methods for the classification of P. vivax genotyping data. Graphical abstract: Created in BioRender. Rosado, J. (2026) https://BioRender.com/p66i686
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P. vivax genotyping samples from these trials provides important proof of concept for the ability of molecular surveillance to inform on relapse burden in not only clinical trials but also potentially broader surveillance frameworks to inform on drivers of resurgence and reservoirs of transmission before and after intervention changes [32].”
From Building the toolkit to address malaria resurgence and radical cure of vivax malaria in Ethiopia: a meeting report (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Real-Time PCR for Detection and Identification of Plasmodium spp
Mangold, K. A., Manson, R. U., Koay, E. S. C., Stephens, L., Regner, M., Thomson, R. B., Peterson, L. R., & Kaul, K. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2435-2440.2005 · Cited by 278
Research works printed but not linked: 63
- 10.1371/journal.pmed.1001891 · DOI · Paper page
- 2019, Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs, Sci. Rep, 9, 17790, 10.1038/s41598-019-54203-0 · doi:10.1038/s41598-019-54203-0
- 2025, Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages, Nat. Commun, 16, 7192, 10.1038/s41467-025-62357-x · DOI · Paper page
- 10.1186/s12864-017-4260-y · DOI
- 10.1016/j.pt.2023.11.006 · DOI · Paper page
- 10.1038/s41598-019-39656-7 · DOI · Paper page
- 10.1093/infdis/jiv142 · DOI
- 10.12688/wellcomeopenres.17736.2 · doi:10.12688/wellcomeopenres.17736.2
- 10.1128/AAC.00437-21 · doi:10.1128/aac.00437-21
- 2021, Unraveling the Complexity of Imported Malaria Infections by Amplicon Deep Sequencing, Front. Cell. Infect. Microbiol, 11, 725859, 10.3389/fcimb.2021.725859 · DOI
- 10.1093/infdis/jiac144 · DOI · Paper page
- 2024, Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study. PLOS Glob, Public Health, 4, e0002743
- 10.1111/1755-0998.13622 · DOI
- 2023, Molecular Surveillance of Malaria Using the PF AmpliSeq Custom Assay for Plasmodium falciparum Parasites from Dried Blood Spot DNA Isolates from Peru, Bio Protoc, 13, e4621
- 2023, Malaria Molecular Surveillance in the Peruvian Amazon with a Novel Highly Multiplexed Plasmodium falciparum AmpliSeq Assay, Microbiol. Spectr, 11, e0096022, 10.1128/spectrum.00960-22 · DOI
- 10.1128/AAC.02474-17 · DOI
- 2022, Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh, Malar. J, 21, 218, 10.1186/s12936-022-04236-0 · DOI
- 2024, Genetic diversity of Plasmodium vivax population in northeast Myanmar assessed by amplicon sequencing of PvMSP1 and PvMSP3α, Acta Trop, 260, 107461, 10.1016/j.actatropica.2024.107461 · DOI
- 2025, Molecular epidemiology and genetic diversity of disappearing Plasmodium vivax in southern Thailand, Sci. Rep, 15, 2620, 10.1038/s41598-025-86578-8 · DOI
- 2023, Amplicon deep sequencing of five highly polymorphic markers of Plasmodium falciparum reveals high parasite genetic diversity and moderate population structure in Ethiopia, Malar. J, 22, 376, 10.1186/s12936-023-04814-w · DOI
- 2023, Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand, Infect. Genet. Evol, 113, 105467, 10.1016/j.meegid.2023.105467 · doi:10.1016/j.meegid.2023.105467
- 10.1038/s41467-023-39417-1 · DOI
- 2024, Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites, Nat. Commun, 15, 6757, 10.1038/s41467-024-51015-3 · DOI · Paper page
- 2022, Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales, Front. Cell. Infect. Microbiol, 12, 953187, 10.3389/fcimb.2022.953187 · DOI
- 10.1371/journal.pntd.0011879 · DOI
- 2024, High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes, Nat. Commun, 15, 10219, 10.1038/s41467-024-54731-y · DOI · Paper page
- 10.1101/2025.04.30.25326751 · doi:10.1101/2025.04.30.25326751
- 10.3389/fmala.2025.1604498 · DOI
- 10.1371/journal.pntd.0009165 · DOI
- 10.12688/f1000research.129581.1 · doi:10.12688/f1000research.129581.1
- 2021, Temporal and Microspatial Heterogeneity in Transmission Dynamics of Coendemic Plasmodium vivax and Plasmodium falciparum in Two Rural Cohort Populations in the Peruvian Amazon, J. Infect. Dis, 223, 1466, 10.1093/infdis/jiaa526 · DOI
- 2017, High prevalence of very-low Plasmodium falciparum and Plasmodium vivax parasitaemia carriers in the Peruvian Amazon: insights into local and occupational mobility-related transmission, Malar. J, 16, 415, 10.1186/s12936-017-2063-x · DOI
- 10.1186/1475-2875-9-361 · DOI · Paper page
- 10.1038/ng.3599 · DOI · Paper page
- 10.1093/bioinformatics/btp352 · DOI · Paper page
- 10.1093/nar/gks596 · DOI · Paper page
- 10.1093/bioinformatics/btp450 · DOI · Paper page
- 10.1590/s0074-02762009000100011 · DOI
- 10.1371/journal.pntd.0007876 · DOI
- 10.1093/genetics/iyac126 · DOI · Paper page
- 10.1093/bioinformatics/btaf643 · DOI · Paper page
- 10.1186/1475-2875-10-297 · DOI · Paper page
- 10.1016/j.pt.2013.05.004 · DOI
- 2021, Anti-malarial drug effects on parasite dynamics in vivax malaria, Malar. J, 20, 161, 10.1186/s12936-021-03700-7 · DOI
- 10.1179/2047773215Y.0000000012 · doi:10.1179/2047773215y.0000000012
- 10.1093/infdis/jir806 · DOI · Paper page
- 10.1086/512242 · DOI · Paper page
- 2022, Hypnozoite depletion in successive Plasmodium vivax relapses, PLoS Negl. Trop. Dis, 16, e0010648, 10.1371/journal.pntd.0010648 · DOI
- 10.1186/1475-2875-13-8 · doi:10.1186/1475-2875-13-8
- 10.1186/s13073-018-0563-0 · DOI · Paper page
- 10.1093/infdis/jis391 · doi:10.1093/infdis/jis391
- 10.1371/journal.pone.0049871 · doi:10.1371/journal.pone.0049871
- 10.1371/journal.pone.0066041 · DOI
- 10.1186/1475-2875-12-429 · DOI
- 10.1128/mBio.01888-17 · DOI
- 10.1056/NEJMc2023884 · doi:10.1056/nejmc2023884
- 2019, Resolving the cause of recurrent Plasmodium vivax malaria probabilistically, Nat. Commun, 10, 5595, 10.1038/s41467-019-13412-x · DOI · Paper page
- 10.1086/512677 · DOI · Paper page
- 2008, Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria, Am. J. Trop. Med. Hyg, 79, 378, 10.4269/ajtmh.2008.79.378 · DOI
- 10.1128/CMR.00051-10 · DOI · Paper page
- 2017, Malaria eradication and the hidden parasite reservoir, Trends Parasitol, 33, 492, 10.1016/j.pt.2017.03.002 · doi:10.1016/j.pt.2017.03.002
- 10.1186/s12936-016-1641-7 · doi:10.1186/s12936-016-1641-7
- 10.1371/journal.pntd.0002882 · DOI · Paper page
Cited by
Degaga, T. S., Sime, H., Ruybal-Pesántez, S., Osborne, A., Mwaura, M., Bamboro, S. A., Mnjala, H., Mekonnen, G., Ermias, S., Fantahun, A., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-06050-4 · Cited by 1
Self-citation
Metadata
- Authors
- Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S.
- Publisher
- openRxiv
- Published
- 2025-05-26
- Cited by
- 6
- References
- 1
- Type
- Preprint
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification. https://app.cochat.ai/papers/10.1101/2025.05.26.25327775
- The paper
- Rosado, J., Han, J., Obadia, T., Munro, J., Traore, Z., Schoffer, K., Brewster, J., Bourke, C., Vinetz, J. M., Taylor, A. R., White, M., Bahlo, M., Gamboa, D., Mueller, I., & Ruybal-Pesántez, S. (2025). Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification. https://doi.org/10.1101/2025.05.26.25327775
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.